Your prediction
NeuroVive Pharmaceutical AB Stock
Heavy losses for NeuroVive Pharmaceutical AB today as the stock fell by -€0.013 (-58.990%).
Pros and Cons of NeuroVive Pharmaceutical AB in the next few years
Pros
?
B****
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Cons
?
M***** P*******
?
S********** s********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of NeuroVive Pharmaceutical AB vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
NeuroVive Pharmaceutical AB | -58.990% | 74.510% | 3.488% | -32.061% | -27.642% | -84.708% | -91.010% |
BioInvent International AB | 3.810% | 8.952% | 31.193% | 41.584% | 74.390% | -46.939% | -6.992% |
India Globalization Capital | -1.740% | 4.147% | 22.162% | 85.246% | 72.519% | -60.211% | -52.720% |
Celsion Corp. | -2.260% | -6.475% | 9.244% | 16.071% | 118.487% | -90.731% | -94.964% |